Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT00276835
What this trial is testing

Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
Northwestern University 15
Early research (Phase 1)Study completedNCT00765921
What this trial is testing

Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma

Who this might be right for
Choroidal Melanoma
Massachusetts Eye and Ear Infirmary 40
Not applicableStudy completedNCT02883933
What this trial is testing

Clinical and Histological Features of Head and Neck Melanoma

Who this might be right for
Melanoma
CHU de Reims 1,548
Not applicableEnrolling By InvitationNCT06388252
What this trial is testing

Electrochemotherapy Changes in Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Melanoma Patients

Who this might be right for
Cutaneous Malignant Melanoma
Institute of Oncology Ljubljana 10
Testing effectiveness (Phase 2)Ended earlyNCT04152863
What this trial is testing

Efficacy, Safety, and Tolerability of Gebasaxturev (V937) Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)

Who this might be right for
Advanced/Metastatic Melanoma
Merck Sharp & Dohme LLC 85
Testing effectiveness (Phase 2)Study completedNCT00204516
What this trial is testing

Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens

Who this might be right for
Malignant Melanoma
University Hospital Tuebingen 31
Early research (Phase 1)Study completedNCT04096638
What this trial is testing

Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors

Who this might be right for
MelanomaHead and Neck Squamous Cell CarcinomaSolid Tumor
invoX Pharma Limited 61
Testing effectiveness (Phase 2)Study completedNCT02583516
What this trial is testing

Clinical Trial to Evaluate the Efficacy of Vemurafenib in Combination With Cobimetinib (Continuous and Intermittent) in BRAFV600-mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma

Who this might be right for
Melanoma
Grupo Español Multidisciplinar de Melanoma 70
Not applicableStudy completedNCT03584334
What this trial is testing

18FDG PET for Early Identification of Tumor Exhaust for Immunotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Bronchopulmonary Carcinoma or Melanoma

Who this might be right for
Non-Small Cell Bronchopulmonary Carcinoma or Melanoma
Centre Antoine Lacassagne 100
Testing effectiveness (Phase 2)Ended earlyNCT04899921
What this trial is testing

Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets

Who this might be right for
MelanomaMetastatic Melanoma
Dana-Farber Cancer Institute 1
Early research (Phase 1)UnknownNCT06556004
What this trial is testing

Phase 1 Study Using TRIMELVax for Stage IIIC / IV Melanoma Patients

Who this might be right for
Melanoma Stage IIIcMelanoma Stage IV
University of Chile 20
Large-scale testing (Phase 3)Active Not RecruitingNCT02339571
What this trial is testing

A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma

Who this might be right for
Stage III Cutaneous Melanoma AJCC v7Stage IV Cutaneous Melanoma AJCC v6 and v7
National Cancer Institute (NCI) 600
Testing effectiveness (Phase 2)Study completedNCT01258855
What this trial is testing

Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Metastatic MelanomaRecurrent MelanomaStage III Cutaneous Melanoma AJCC v7+4 more
National Cancer Institute (NCI) 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT06717126
What this trial is testing

A Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal Melanoma

Who this might be right for
Uveal MelanomaOcular Melanoma
iOnctura 85
Testing effectiveness (Phase 2)Study completedNCT00866177
What this trial is testing

MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Recurrent MelanomaStage III Skin MelanomaStage IV Skin Melanoma
National Cancer Institute (NCI) 167
Testing effectiveness (Phase 2)Study completedNCT03052127
What this trial is testing

Study in Subjects With Small Primary Choroidal Melanoma

Who this might be right for
Uveal MelanomaOcular MelanomaChoroidal Melanoma
Aura Biosciences 57
Large-scale testing (Phase 3)Ended earlyNCT05002569
What this trial is testing

Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 1,093
Testing effectiveness (Phase 2)Ended earlyNCT03911869
What this trial is testing

An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis

Who this might be right for
Brain Metastases
Pfizer 13
Early research (Phase 1)UnknownNCT02637531
What this trial is testing

A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549

Who this might be right for
Advanced Solid Tumors (Part A/B/C/D)Non-small Cell Lung Cancer (Part E)Melanoma (Part E)+5 more
Infinity Pharmaceuticals, Inc. 219
Testing effectiveness (Phase 2)Study completedNCT00470470
What this trial is testing

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Acral Lentiginous Malignant MelanomaRecurrent MelanomaStage IIIA Melanoma+3 more
National Cancer Institute (NCI) 30
Next Page